Title |
Computational analyses of curcuminoid analogs against kinase domain of HER2
|
---|---|
Published in |
BMC Bioinformatics, August 2014
|
DOI | 10.1186/1471-2105-15-261 |
Pubmed ID | |
Authors |
Wannarat Yim-im, Orathai Sawatdichaikul, Suwanna Semsri, Natharinee Horata, Wanwimon Mokmak, Sissades Tongsima, Apichart Suksamrarn, Kiattawee Choowongkomon |
Abstract |
Human epidermal growth factor receptor 2 (HER2) has an important role in cancer aggressiveness and poor prognosis. HER2 has been used as a drug target for cancers. In particular, to effectively treat HER2-positive cancer, small molecule inhibitors were developed to target HER2 kinase. Knowing that curcumin has been used as food to inhibit cancer activity, this study evaluated the efficacy of natural curcumins and curcumin analogs as HER2 inhibitors using in vitro and in silico studies. The curcumin analogs considered in this study composed of 4 groups classified by their core structure, β-diketone, monoketone, pyrazole, and isoxazole. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Norway | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 67% |
Members of the public | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Iran, Islamic Republic of | 1 | 1% |
Malaysia | 1 | 1% |
Unknown | 84 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 21 | 24% |
Student > Ph. D. Student | 10 | 12% |
Student > Master | 8 | 9% |
Researcher | 5 | 6% |
Student > Doctoral Student | 5 | 6% |
Other | 19 | 22% |
Unknown | 18 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 18 | 21% |
Chemistry | 12 | 14% |
Agricultural and Biological Sciences | 8 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
Engineering | 5 | 6% |
Other | 15 | 17% |
Unknown | 21 | 24% |